Tumor cells fused with dendritic cells via expression of viral fusogenic membrane glycoproteins as potential anti-tumor vaccines.

被引：0
|
作者：
Melcher, AA [1 ]
Bateman, AR [1 ]
Linardakis, E [1 ]
Russell, SJ [1 ]
Vile, RG [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Program Mol Med, Rochester, MN 55905 USA
来源：
GENE THERAPY | 1999年 / 6卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
11
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells
    Bateman, AR
    Harrington, KJ
    Kottke, T
    Ahmed, A
    Melcher, AA
    Gough, MJ
    Linardakis, E
    Riddle, D
    Dietz, A
    Lohse, CM
    Strome, S
    Peterson, T
    Simari, R
    Vile, RG
    CANCER RESEARCH, 2002, 62 (22) : 6566 - 6578
  • [2] Targeted immunotherapy - The use of dendritic cells in anti-tumor vaccines
    Hospers, GAP
    van Zanten, J
    Mulder, NH
    de Leij, LFMH
    MOLECULAR BIOLOGY IN BLOOD TRANSFUSION, 2000, 35 : 235 - 241
  • [3] From glycals to evaluatable anti-tumor vaccines.
    Ragupathi, G
    Livingston, PO
    Danishefsky, SJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U224 - U224
  • [4] Effect of lipopolysaccharide on dendritic cells and anti-tumor immune response between dendritic cells fused with prostate cancer cells and tumor lysate-pulsed dendritic cells
    Doo, C. K.
    Yoo, C.
    Song, C.
    Min, G. E.
    Chung, H.
    Kim, C. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 81 - 81
  • [5] Gene-modified dendritic cells as vaccines for the induction of anti-tumor immunity
    Pezzutto, A
    Westermann, J
    SYMPOSIUM IN IMMUNOLOGY VI: TUMOR IMMUNOLOGY, 1997, : 89 - 101
  • [6] Anti-tumor effects produced by the expression of fas ligand on tumor cells are mediated by the activation of dendritic cells
    Tagawa, M
    Tada, Y
    O-Wang, J
    Sakiyama, S
    CANCER GENE THERAPY, 2001, 8 : S28 - S28
  • [7] Raav vector transduction of dendritic cells (DC) for development of tumor specific vaccines.
    Krouse, RS
    Forman, SJ
    Wong, KK
    Chatterjee, S
    BLOOD, 1998, 92 (10) : 146A - 147A
  • [8] Superior anti-tumor immune response of dendritic cells fused with prostate cancer cell lines compared with tumor lysate-pulsed dendritic cells
    Lee, SB
    Lee, JM
    Jun, SY
    Yoo, C
    Song, SH
    JOURNAL OF UROLOGY, 2006, 175 (04): : 143 - 143
  • [9] Development of anti-tumor vaccines using nucleofection of tumor-derived DNA into human dendritic cells (DC)
    Artusio, E.
    Hathaway, B.
    Stanson, J.
    Whiteside, T.
    CYTOTHERAPY, 2006, 8
  • [10] Anti-tumor effector function of dendritic cells.
    Shimamura, H
    Cumberland, R
    Lotze, MT
    Baar, J
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 47 - 47
12345